The five-year survival rate for patients with gastrointestinal mesenchymal tumors without metastases is between 50% and 60% after complete surgical resection. Patients who cannot undergo complete surgical resection or have metastasis have a five-year survival rate of less than 35% and a ten-year survival rate of only about 17%.
Gastrointestinal mesenchymal tumors have a good prognosis, and the survival time of patients is related to a variety of factors such as the degree of malignancy of the tumor, the site of growth, and the individual’s physical condition. For treatment, preoperative evaluation using imaging should be performed first. If there is no distant metastasis and the mass can be completely resected, radical surgery should be performed, and target therapy such as imatinib should be applied selectively according to pathological staging after surgery.
Patients with gastrointestinal mesenchymal tumors should keep their bowel movement smooth, and at the same time, they should maintain a positive and optimistic mindset to cooperate with the doctor’s treatment. The medication should follow the doctor’s instructions, the diet should be kept light, try to easy digestion, less residue food as the main, eat less and more meals. If discomfort occurs, it should be detected and treated early to avoid aggravating the condition.